Po‐Ting Lin

Methodological Considerations Regarding a TriNetX Comparison of First‐Line Therapies for HCC

Wei Teng, Po‐Ting Lin, Chun‐Yen Lin

The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

tw (code pays fourni par la source)

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma

Pasquale Lombardi, Erik Ramon‐Gil, Rabial Q. Raja, Leonardo Brunetti et autres

BACKGROUND & AIMS: Despite improved outcomes with atezolizumab plus bevacizumab (A+B) in hepatocellular carcinoma, primary refractoriness (PRef), characterised by early progression or short-lived disease stabilisation following treatment, remains a significant challenge. METHODS: We analysed 1,296 patients with hepatocellular carcinoma treated with frontline …

it, gb, es, kr, us, at, tw, jp, de, no, be (code pays fourni par la source)

Unveiling “Idiopathic” Nocturia: The Central Role of Sleep‐Induced Hypogonadism and ANP‐Mediated Hemodynamics

Po‐Ting Lin, Jau‐Yuan Chen, Yu‐Hsiang Lin

This Letter to the Editor is based on previously published literature and does not involve any new data collected by the authors. All analyses and discussions are derived from publicly available sources, which are cited within the manuscript. Therefore, there are no …

tw (code pays fourni par la source)

Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis

Yuan‐Hung Kuo, Wei Teng, Yen‐Hao Chen, Po‐Ting Lin et autres

Background and Aims: The prognostic nutritional index (PNI), calculated from serum albumin and lymphocyte count, reflects a patient's immune-nutritional status and has been proposed as a prognostic marker in hepatocellular carcinoma (HCC). However, its role in advanced HCC patients treated with atezolizumab …

tw (code pays fourni par la source)

Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

Yuan‐Hung Kuo, Wei Teng, Po‐Ting Lin, Yen‐Hao Chen et autres

INTRODUCTION: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality, particularly in patients with advanced stage. Atezolizumab plus bevacizumab (Ate/Bev) is the standard first-line therapy; however, its efficacy may be further enhanced using combination strategies. METHODS: This study evaluated the clinical …

tw (code pays fourni par la source)

Systemic endocrine benefits of benign prostatic obstruction surgery

Po‐Ting Lin, Chien-Lun Chen, Yu-Hsiang Lin

tw (code pays fourni par la source)

Reply: Revisiting FOXP3 expression and its prognostic implications in hepatocellular carcinoma

Chien‐Hao Huang, Wei-Ting Ku, Tsung-Han Wu, Po‐Ting Lin et autres

tw (code pays fourni par la source)

Mesenteric pneumatosis on CT: a predictor of benign pneumatosis intestinalis

Po‐Jui Lu, Rheun‐Chuan Lee, Nai‐Chi Chiu, Po‐Ting Lin et autres

tw (code pays fourni par la source)

Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradication

Wei Teng, Wei-Ting Ku, Po‐Ting Lin, Guanting Chen et autres

BACKGROUND: Direct-acting antiviral (DAA) therapy for chronic hepatitis C (CHC) achieves high sustained virologic response (SVR) rates; however, hepatocellular carcinoma (HCC) can still develop after viral eradication. Reliable biomarkers for predicting the post-SVR HCC risk are lacking. This study aimed to identify …

tw (code pays fourni par la source)

Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC

Chien‐Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, Cheng‐Heng Wu et autres

BACKGROUND AND AIMS: CD4 + regulatory T cells (Tregs) are pivotal in HCC progression. However, systemic depletion of all Tregs risks autoimmunity. Existing subgroup classifications highlight Tregs' phenotypic and functional heterogeneity but lack coherent consensus. This study aimed to classify Treg subtypes …

tw, in (code pays fourni par la source)

Mesenteric Pneumatosis on CT: A Predictor of Benign Pneumatosis Intestinalis

Po‐Jui Lu, Rheun‐Chuan Lee, Nai‐Chi Chiu, Po‐Ting Lin et autres

tw (code pays fourni par la source)

THU-112 Proinflammatorycytokines drive peripheral Foxp3high Tregs into tumor sites: a reliable and accessible prognostic biomarker for HCC patients

Chien‐Hao Huang, Tsung‐Han Wu, Po‐Ting Lin, Teng Wei et autres